Acute phenylalanine/tyrosine depletion: A new method to study the role of catecholamines in psychiatric disorders

Primary Psychiatry

Volumn 11, Issue 6, 2004, Pages 37-41

  Barrett, Sean P ^a   Leyton, Marco ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; PHENYLALANINE; TYROSINE;

ACUTE PHENYLALANINE TYROSINE DEPLETION; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; BEHAVIOR; BIPOLAR DISORDER; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; HUMAN; MENTAL DISEASE; MOTIVATION; NEUROTRANSMITTER RELEASE; NONHUMAN; REINFORCEMENT; REVIEW; TECHNIQUE;

EID: 3042817432     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Grace AA, Gerfen CR, Aston-Jones G. Catecholamines in the central nervous system. Overview. Adv Pharmacol. 1998;42:655-670.
2. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Bio Psychiatry. 1998;44(10):951-958.
3. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59(suppl 14):11-14.
4. Koob GF. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci. 2000;909:170-185.
5. Leyton M, Young SN, Pihl RO, et al. Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology. 2000;22(1):52-63.
6. Biggio G, Porceddu ML, Gessa GL. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3′,5′-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine. J Neurochem. 1976;26(6):1253-1255.
7. Moja EA, Lucini V, Benedetti F, Lucca A. Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man. Life Sci. 1996;58(26):2389-2395.
8. McTavish SF, Cowen PJ, Sharp T. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl). 1999;141(2):182-188.
9. Palmour RM, Ervin FR, Baker GB, Young SN. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl). 1998;136(1):1-7.
10. McTavish SF, Raumann B, Cowen PJ, Sharp T. Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats. Eur J Pharmacol. 2001;424(2):115-119.
11. Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl). 2001;154(1):105-111.
12. Montgomery AJ, McTavish SF, Cowen PJ, Grasby PM. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study. Am J Psychiatry. 2003;160(10):1887-1889.
13. Leyton M, Dagher A, Boileau I, et al. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology. 2004;29(2):427-432.
14. Butcher LL, Engel J. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition. Brain Res. 1969;15(1):233-242.
15. Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4- dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease. Acta Neurol Scand. 1995;92(2):116-121.
16. McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry. 2001;179:356-360.
17. Casey K, Benkelfat C, Young SN, et al. Catecholamine depletion reduces nicotine withdrawal related craving but not self-administration in nicotine dependent smokers. Paper presented at: the American College of Neuropsychopharmacology Annual Meeting; December 9-12, 2002; San Juan, Puerto Rico.
18. Remington G. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target. J Psychiatry Neurosci. 2003;28(4):275-284.
19. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ. The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl). 2004;171(3):286-297.
20. Leyton M, Rot aan het M, Boileau I, et al. Acute phenylalanine/tyrosine depletion in humans. Paper presented at: the 21st Annual European Winter Conference on Brain Research; March 3-10, 2001; Arc 1800, France.
21. Leyton M, Young SN, Blier P, Baker GB, Pihl RO, Benkelfat C. Acute tyrosine depletion and alcohol ingestion in healthy women. Alcohol Clin Exp Res. 2000;24(4):459-464.
22. McTavish SF, McPherson MH, Sharp T, Cowen PJ. Attenuation of some subjective effects of amphetamine following tyrosine depletion. J Psychopharmacol. 1999;13(2):144-147.
23. Coupland N, Zedkova L, Sanghera G, Leyton M, Le Melledo JM. Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study. J Psychiatry Neurosci. 2001;26(3):247-251.
24. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20(1):1-25.
25. Pfaus JG, Damsma G, Wenkstern D, Fibiger HC. Sexual activity increases dopamine transmission in the nucleus accumbens and striatum of female rats. Brain Res. 1995;693(1-2):21-30.
26. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol. 1996;6(2):243-251.
27. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999;22(11):521-527.
28. Horger BA, Roth RH. The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol. 1996;10(3-4):395-418.
29. Hooks MS, Kalivas PW. The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation. Neuroscience. 1995;64(3):587-597.
30. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36(2):241-263.
31. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction. 2000;95(suppl 2):S91-S117.
32. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extra-cellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci U S A. 2000;97(8):4321-4326.
33. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002;54(1):1-42.
34. Swann AC, Petty F, Bowden CL, Dilsaver SC, Calabrese JR, Morris DD. Mania: gender, transmitter function, and response to treatment. Psychiatry Res. 1999;88(1):55-61.
35. Craddock N, Dave S, Greening J. Association studies of bipolar disorder. Bipolar Disord. 2001;3(6):284-298.
36. Gijsman HJ, Scarna A, Harmer CJ, et al. A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology (Berl). 2002;160(2):192-197.
37. Scarna A, Gijsman HJ, McTavish SF, Harmer CJ, Cowen PJ, Goodwin GM. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry. 2003;182:210-213.